The healthcare industry can breathe a little easier, at least for now. Amazon has backed off on its plans to sell pharmaceutical products to hospitals. Logistical concerns are part of the pull-back, which is kind of surprising since that’s like Amazon’s whole thing, right? Turns out, cold chain is hard. It’s actually more than just that—while Amazon certainly has brand recognition to go around, not even it can disrupt loyal vendor relationships maintained between hospitals, drug distributors, and group purchasing organizations. Pharmacies and drug distributor stocks went up after the announcement, but they better keep their heads on a swivel—there’s still that health venture with Berkshire and JPMorgan to be worried about. Last we heard, they were on a CEO search.